Cargando…
A molecular basis for neurofibroma-associated skeletal manifestations in NF1
PURPOSE: Plexiform neurofibromas (NF) develop in children with Neurofibromatosis Type 1 (NF1) and can be associated with several skeletal co-morbidities. Preclinical mouse studies revealed Nf1 deficiency in osteoprogenitor cells disrupts, in a MEK-dependent manner, pyrophosphate (PPi) homeostasis an...
Autores principales: | Ma, Yun, Gross, Andrea, Dombi, Eva, Pemov, Alex, Choi, Kwangmin, Chaney, Katherine, Rhodes, Steven D., Angus, Steven P, Sciaky, Noah, Clapp, D Wade, Ratner, Nancy, Widemann, Brigitte C, Rios, Jonathan J, Elefteriou, Florent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106869/ https://www.ncbi.nlm.nih.gov/pubmed/32601387 http://dx.doi.org/10.1038/s41436-020-0885-3 |
Ejemplares similares
-
STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma
por: Fletcher, Jonathan S., et al.
Publicado: (2018) -
Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1
por: Nguyen, Rosa, et al.
Publicado: (2012) -
MicroRNA-155 contributes to plexiform neurofibroma growth downstream of MEK
por: Na, Youjin, et al.
Publicado: (2020) -
Clinical trial design for cutaneous neurofibromas
por: Cannon, Ashley, et al.
Publicado: (2018) -
Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment
por: Kershner, Leah J., et al.
Publicado: (2022)